| Wall Street Journal. Europe 2001 Carey Sargent |
| Title | Subject | Authors |
|---|
| Actelion nears launch of drug after U.S. regulatory action. | Business, international | Carey Sargent |
| Analysts see solid results from Germany's Merck. | Business, international | Carey Sargent |
| BASF earnings disappoint as sales decline by 22%. | Business, international | Carey Sargent |
| BASF operating profit rises, but some divisions struggle. | Business, international | Carey Sargent |
| Bayer to report weak results for third quarter. | Business, international | Carey Sargent |
| Celanese again cuts earnings estimates for the full year.(2001 earnings forecasts) | Business, international | Carey Sargent |
| Clariant's revenue falls on slowdown. | Business, international | Carey Sargent |
| CropScience results improve prospects for sale by Aventis. | Business, international | Carey Sargent |
| Degussa to sell dental unit to Dentsply for 576 million euros. | Business, international | Carey Sargent |
| Kuoni Reisen ends dispute with chairman (Kuoni Reisen Holding's chairman Daniel Affolter resigns). | Business, international | Carey Sargent |
| Operating profit declines by 17% at BASF.(German company's outlook for the mid-term is gloomy.) | Business, international | Carey Sargent |
| Possibility of UBS bid lifts Sarasin shares 12%. | Business, international | Carey Sargent |
| Schering offers optimistic view on Net for year. | Business, international | Carey Sargent |
| Schering will take a stake MorphoSys and fund research. | Business, international | Carey Sargent |
| Serono posts sales below expectations for third quarter. | Business, international | Carey Sargent |
| Serono reported a 14% jump in sales for the first quarter. | Business, international | Carey Sargent |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
